Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edouard Auclin

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 6, 2022
TIVAP-related infection due to Gram-negative aerobic bacilli: should TIVAP stay or should it go?Simon Rolland, Najiby Kassis-Chikhani, Edouard Auclin, et al.
Frontiers in Psychiatry|September 20, 2021
Association Between Psychological Distress, Cognitive Complaints, and Neuropsychological Status After a Severe COVID-19 Episode: A Cross-Sectional StudyClément Gouraud, Hugo Bottemanne, Khadija Lahlou-Laforêt, et al.
Clinical Genitourinary Cancer|December 15, 2016
Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Metastatic Urothelial Carcinoma Patients Treated With First-line Chemotherapy: A Large Multicenter StudyMarie Auvray, Reza Elaidi, Mustafa Ozguroglu, et al.
Lung Cancer (Amsterdam, Netherlands)|November 29, 2024
Validation of the Lung Immune Prognostic Index in patients with untreated advanced non-small cell lung cancer: Post hoc analysis of the IMpower 130, 131 and 150 trialsEdouard Auclin, Matthieu Roulleaux Dugage, Teresa Gorria, et al.
Current Oncology Reports|October 18, 2022
Biological Rationale for Peripheral Blood Cell-Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung CancerGiuseppe Luigi Banna, Alex Friedlaender, Marco Tagliamento, et al.
Lung Cancer (Amsterdam, Netherlands)|April 2, 2021
Pleural effusion is a negative prognostic factor for immunotherapy in patients with non-small cell lung cancer (NSCLC): The pluie studyNicolas Epaillard, Jose Carlos Benitez, Teresa Gorria, et al.
Cancers|December 8, 2020
Integrating Circulating Biomarkers in the Immune Checkpoint Inhibitor Treatment in Lung CancerBoris Duchemann, Jordi Remon, Marie Naigeon, et al.
Cancer Medicine|August 12, 2021
Cabazitaxel multiple rechallenges in metastatic castration-resistant prostate cancerCedric Pobel, Edouard Auclin, Diego Teyssonneau, et al.
International Journal of Medical Informatics|September 14, 2024
Real-life implementation and evaluation of the e-referral system SIPILINKAimé Nun, Anne-Isabelle Tropeano, Edouard Flamarion, et al.
Frontiers in Medicine|July 5, 2022
Hepatic Arterial Infusion Chemotherapy With Folfirinox or Oxaliplatin Alone in Metastatic Colorectal CancerViolaine Randrian, Simon Pernot, Baptiste Sionneau, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 6, 2022
TIVAP-related infection due to Gram-negative aerobic bacilli: should TIVAP stay or should it go?Simon Rolland, Najiby Kassis-Chikhani, Edouard Auclin, et al.
Frontiers in Psychiatry|September 20, 2021
Association Between Psychological Distress, Cognitive Complaints, and Neuropsychological Status After a Severe COVID-19 Episode: A Cross-Sectional StudyClément Gouraud, Hugo Bottemanne, Khadija Lahlou-Laforêt, et al.
Clinical Genitourinary Cancer|December 15, 2016
Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Metastatic Urothelial Carcinoma Patients Treated With First-line Chemotherapy: A Large Multicenter StudyMarie Auvray, Reza Elaidi, Mustafa Ozguroglu, et al.
Lung Cancer (Amsterdam, Netherlands)|November 29, 2024
Validation of the Lung Immune Prognostic Index in patients with untreated advanced non-small cell lung cancer: Post hoc analysis of the IMpower 130, 131 and 150 trialsEdouard Auclin, Matthieu Roulleaux Dugage, Teresa Gorria, et al.
Current Oncology Reports|October 18, 2022
Biological Rationale for Peripheral Blood Cell-Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung CancerGiuseppe Luigi Banna, Alex Friedlaender, Marco Tagliamento, et al.
Lung Cancer (Amsterdam, Netherlands)|April 2, 2021
Pleural effusion is a negative prognostic factor for immunotherapy in patients with non-small cell lung cancer (NSCLC): The pluie studyNicolas Epaillard, Jose Carlos Benitez, Teresa Gorria, et al.
Cancers|December 8, 2020
Integrating Circulating Biomarkers in the Immune Checkpoint Inhibitor Treatment in Lung CancerBoris Duchemann, Jordi Remon, Marie Naigeon, et al.
Cancer Medicine|August 12, 2021
Cabazitaxel multiple rechallenges in metastatic castration-resistant prostate cancerCedric Pobel, Edouard Auclin, Diego Teyssonneau, et al.
International Journal of Medical Informatics|September 14, 2024
Real-life implementation and evaluation of the e-referral system SIPILINKAimé Nun, Anne-Isabelle Tropeano, Edouard Flamarion, et al.
Frontiers in Medicine|July 5, 2022
Hepatic Arterial Infusion Chemotherapy With Folfirinox or Oxaliplatin Alone in Metastatic Colorectal CancerViolaine Randrian, Simon Pernot, Baptiste Sionneau, et al.
Pageof 9